D Bear - JoVE Visualize

Showing results (41-50 of 188) with videos related to

Pageof 19

Sort By:

Journal of Bacteriology|April 1, 1996

Characterization of the stable maintenance properties of the par region of broad-host-range plasmid RK2P A Sobecky, C L Easter, P D Bear, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1990

Activation and expansion of cytotoxic T lymphocytes from tumor-draining lymph nodesJ G McKinnon, S K Hoover, T H Inge, et al.

Ultramicroscopy|July 1, 1992

Electrodeposition procedure of E. coli RNA polymerase onto gold and deposition of E. coli RNA polymerase onto mica for observation with scanning force microscopyR W Keller, D J Keller, D Bear, et al.

Journal of Visualized Experiments : Jove|February 10, 2011

Ex vivo expansion of tumor-reactive T cells by means of bryostatin 1/ionomycin and the common gamma chain cytokines formulationMaciej Kmieciak, Amir Toor, Laura Graham, et al.

Cancer Drug Resistance (Alhambra, Calif.)|September 30, 2022

Persistent EGFR/K-RAS/SIAH pathway activation drives chemo-resistance and early tumor relapse in triple-negative breast cancerAmy H Tang, Richard A Hoefer, Mary L Guye, et al.

Neurological Research|April 1, 1997

Adoptive immunotherapy of malignant glioma using tumor-sensitized T lymphocytesR E Merchant, N G Baldwin, C D Rice, et al.

Clinical Breast Cancer|June 18, 2026

Tracking Utilization of Neoadjuvant Endocrine Therapy (NET) and Neoadjuvant Chemotherapy (NCT) for Hormone Receptor-Positive Breast Cancer (HR + BC) in the U.S.A. Over Time - A TriNetX Database StudyJubin K Lim, Anna E Gibson, Jian He, et al.

American Journal of Surgery|April 1, 1984

Colon and rectal carcinoma in the west of Scotland. Symptoms, histologic characteristics, and outcomeH D Bear, J MacIntyre, H J Burns, et al.

Journal of Investigative Medicine High Impact Case Reports|October 16, 2023

Unexpected Clinical Outcome for Myxoinflammatory Fibroblastic Sarcoma, When Should They Be Considered High Grade?Brian K Sparkman, Tuong Vi V Nguyen, Steven Christopher Smith, et al.

Cellular Immunology|August 1, 1992

Different signaling pathways induced by alpha-CD3 monoclonal antibody versus alloantigen on the basis of differential ornithine sensitivityP Mehrotra nee Tandon, D S Lind, H D Bear, et al.

Pageof 19

Showing results (41-50 of 188) with videos related to

Sort By:

Pageof 19

Journal of Bacteriology|April 1, 1996

Characterization of the stable maintenance properties of the par region of broad-host-range plasmid RK2P A Sobecky, C L Easter, P D Bear, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1990

Activation and expansion of cytotoxic T lymphocytes from tumor-draining lymph nodesJ G McKinnon, S K Hoover, T H Inge, et al.

Ultramicroscopy|July 1, 1992

Electrodeposition procedure of E. coli RNA polymerase onto gold and deposition of E. coli RNA polymerase onto mica for observation with scanning force microscopyR W Keller, D J Keller, D Bear, et al.

Journal of Visualized Experiments : Jove|February 10, 2011

Ex vivo expansion of tumor-reactive T cells by means of bryostatin 1/ionomycin and the common gamma chain cytokines formulationMaciej Kmieciak, Amir Toor, Laura Graham, et al.

Cancer Drug Resistance (Alhambra, Calif.)|September 30, 2022

Persistent EGFR/K-RAS/SIAH pathway activation drives chemo-resistance and early tumor relapse in triple-negative breast cancerAmy H Tang, Richard A Hoefer, Mary L Guye, et al.

Neurological Research|April 1, 1997

Adoptive immunotherapy of malignant glioma using tumor-sensitized T lymphocytesR E Merchant, N G Baldwin, C D Rice, et al.

Clinical Breast Cancer|June 18, 2026

Tracking Utilization of Neoadjuvant Endocrine Therapy (NET) and Neoadjuvant Chemotherapy (NCT) for Hormone Receptor-Positive Breast Cancer (HR + BC) in the U.S.A. Over Time - A TriNetX Database StudyJubin K Lim, Anna E Gibson, Jian He, et al.

American Journal of Surgery|April 1, 1984

Colon and rectal carcinoma in the west of Scotland. Symptoms, histologic characteristics, and outcomeH D Bear, J MacIntyre, H J Burns, et al.

Journal of Investigative Medicine High Impact Case Reports|October 16, 2023

Unexpected Clinical Outcome for Myxoinflammatory Fibroblastic Sarcoma, When Should They Be Considered High Grade?Brian K Sparkman, Tuong Vi V Nguyen, Steven Christopher Smith, et al.

Cellular Immunology|August 1, 1992

Different signaling pathways induced by alpha-CD3 monoclonal antibody versus alloantigen on the basis of differential ornithine sensitivityP Mehrotra nee Tandon, D S Lind, H D Bear, et al.

Pageof 19